Furthermore, animal studies have shown that NaV1.7 expression and function are increased in models of diabetic neuropathy, chronic constrictive injury, and chemotherapy-induced peripheral neuropathy [25]. The gene discussed is SCN9A; the disease is diabetic neuropathy.